Cargando…

β-Arrestin–Mediated Angiotensin II Type 1 Receptor Activation Promotes Pulmonary Vascular Remodeling in Pulmonary Hypertension

Pulmonary arterial hypertension (PAH) is a disease of abnormal pulmonary vascular remodeling whose medical therapies are thought to primarily act as vasodilators but also may have effects on pulmonary vascular remodeling. The angiotensin II type 1 receptor (AT(1)R) is a G protein–coupled receptor th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zhiyuan, Viswanathan, Gayathri, Sellig, Mason, Jassal, Chanpreet, Choi, Issac, Garikipati, Aditi, Xiong, Xinyu, Nazo, Nour, Rajagopal, Sudarshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Preclinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617598/ https://www.ncbi.nlm.nih.gov/pubmed/34869949 http://dx.doi.org/10.1016/j.jacbts.2021.09.006

Ejemplares similares

Beta-Arrestins and Receptor Signaling in the Vascular Endothelium
por: Lee, Claudia, et al.
Publicado: (2020)

Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension
por: da Silva Gonçalves Bos, Denielli, et al.
Publicado: (2017)

Endothelial β‐arrestins regulate mechanotransduction by the type II bone morphogenetic protein receptor in primary cilia
por: Park, Saejeong, et al.
Publicado: (2022)

Electrical Vagal Nerve Stimulation Ameliorates Pulmonary Vascular Remodeling and Improves Survival in Rats With Severe Pulmonary Arterial Hypertension
por: Yoshida, Keimei, et al.
Publicado: (2018)

The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension
por: Viswanathan, Gayathri, et al.
Publicado: (2018)

Differential Leaflet Remodeling of Bone Marrow Cell Pre-Seeded Versus Nonseeded Bioresorbable Transcatheter Pulmonary Valve Replacements
por: Fioretta, Emanuela S., et al.
Publicado: (2019)

β-Arrestin–Biased AT(1) Agonist TRV027 Causes a Neonatal-Specific Sustained Positive Inotropic Effect Without Increasing Heart Rate
por: Kashihara, Toshihide, et al.
Publicado: (2020)

SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension
por: Sun, Wei, et al.
Publicado: (2020)

It’s Time to Put the Term “Pulmonary Vasodilators” to Rest
por: Rubin, Lewis J.
Publicado: (2021)

Short-Term Administration of Serelaxin Produces Predominantly Vascular Benefits in the Angiotensin II/L-NAME Chronic Heart Failure Model
por: McCarthy, Joseph C., et al.
Publicado: (2017)

SCUBE Diving: Biomarker Discovery for Pulmonary Hypertension From Bench to Bedside
por: Gomez-Arroyo, Jose, et al.
Publicado: (2020)

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018)

Heart Failure in Pulmonary Arterial Hypertension Is Just a WNK1 Away
por: Ha, Chae-Myeong, et al.
Publicado: (2021)

With No Lysine Kinase 1 Promotes Metabolic Derangements and RV Dysfunction in Pulmonary Arterial Hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2021)

In Vivo Imaging of Venous Thrombus and Pulmonary Embolism Using Novel Murine Venous Thromboembolism Model
por: Okano, Mitsumasa, et al.
Publicado: (2020)

A Novel Mechanism for Mesenchymal Stromal Cells to Induce Long‐Term Suppression of Pulmonary Inflammation
por: Min, Hyunjung, et al.
Publicado: (2021)

Pleiotropic Effects of Pyruvate Kinase M2 in Right Ventricular Failure and Pulmonary Arterial Hypertension
por: Christou, Helen
Publicado: (2022)

Wharton’s Jelly–Mesenchymal Stem Cell–Engineered Conduit for Pulmonary Artery Reconstruction in Growing Piglets
por: Rapetto, Filippo, et al.
Publicado: (2022)

Cut the YAP: Limiting Fibrosis in Pathologic Cardiac Remodeling
por: Small, Eric M., et al.
Publicado: (2020)

PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
por: Shimauchi, Tsukasa, et al.
Publicado: (2022)

In Vivo Imaging of Tissue-Engineered Grafts Within Pulmonary Artery of a Growing Large Animal Model
por: Bates, Novella M., et al.
Publicado: (2022)

Phosphorylation of Hsp20 Promotes Fibrotic Remodeling and Heart Failure
por: Gardner, George T., et al.
Publicado: (2019)

Sodium Nitroprusside–Enhanced Cardiopulmonary Resuscitation Improves Blood Flow by Pulmonary Vasodilation Leading to Higher Oxygen Requirements
por: Ripeckyj, Adrian, et al.
Publicado: (2020)

Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice
por: Mackasey, Martin, et al.
Publicado: (2018)

Bioactive Extracellular Matrix Scaffold Promotes Adaptive Cardiac Remodeling and Repair
por: Mewhort, Holly E.M., et al.
Publicado: (2017)

Rad GTPase Deletion Attenuates Post-Ischemic Cardiac Dysfunction and Remodeling
por: Manning, Janet R., et al.
Publicado: (2018)

Novel Mechanistic Roles for Ankyrin-G in Cardiac Remodeling and Heart Failure
por: Makara, Michael A., et al.
Publicado: (2018)

Pulmonary Vascular Remodeling in Pulmonary Hypertension
por: Jia, Zhuangzhuang, et al.
Publicado: (2023)

Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction
por: Ali, Muhammad, et al.
Publicado: (2016)

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles
por: Goette, Andreas, et al.
Publicado: (2009)

Hydrogen Sulfide Attenuates Renin Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney Function and Improve Exercise Tolerance in Heart Failure
por: Li, Zhen, et al.
Publicado: (2018)

Cathepsin A Mediates Ventricular Remote Remodeling and Atrial Cardiomyopathy in Rats With Ventricular Ischemia/Reperfusion
por: Hohl, Mathias, et al.
Publicado: (2019)

In Situ Remodeling Overrules Bioinspired Scaffold Architecture of Supramolecular Elastomeric Tissue-Engineered Heart Valves
por: Uiterwijk, Marcelle, et al.
Publicado: (2020)

Cardiac Mesenchymal Stem Cells Promote Fibrosis and Remodeling in Heart Failure: Role of PDGF Signaling
por: Hamid, Tariq, et al.
Publicado: (2022)

NADPH Oxidase-4 Driven Cardiac Macrophage Polarization Protects Against Myocardial Infarction–Induced Remodeling
por: Mongue-Din, Heloise, et al.
Publicado: (2017)

CCR2(+) Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload
por: Patel, Bindiya, et al.
Publicado: (2018)

NLRP3 Inflammasome Inhibition: A Potential Therapeutic Strategy to Attenuate Postinfarction Adverse Cardiac Remodeling
por: Narendran, Siddharth, et al.
Publicado: (2020)

Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction
por: Louwe, Mieke C., et al.
Publicado: (2020)

Inhibition of Interleukin-17A, But Not Interleukin-17F, Signaling Lowers Blood Pressure, and Reduces End-Organ Inflammation in Angiotensin II–Induced Hypertension
por: Saleh, Mohamed A., et al.
Publicado: (2016)

JAK2(V617F)-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
por: Sano, Soichi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qs782li90945mkb8rhad6i3ghp